Raf Schepers

Methamphetamine and amphetamine pharmacokinetics in oral fluid and plasma after controlled oral methamphetamine administration to human volunteers.

M. Huestis, E. Cone, E. Moolchan, 2003, Clinical chemistry.

Protection of COVID-19 vaccination and previous infection against Omicron BA.1, BA.2 and Delta SARS-CoV-2 infections

H. D. de Melker, C. Reusken, M. Knol, 2022, Nature Communications.

Increased risk of infection with SARS-CoV-2 Omicron BA.1 compared with Delta in vaccinated and previously infected individuals, the Netherlands, 22 November 2021 to 19 January 2022

H. Vennema, C. Reusken, M. Knol, 2022, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

Correlation of mycophenolic acid pharmacokinetic parameters with side effects in kidney transplant patients treated with mycophenolate mofetil.

J. Squifflet, M. Mourad, P. Wallemacq, 2001, Clinical chemistry.

Pharmacokinetic basis for the efficient and safe use of low-dose mycophenolate mofetil in combination with tacrolimus in kidney transplantation.

J. Squifflet, M. Mourad, P. Wallemacq, 2001, Clinical chemistry.

Nationwide Harmonization Effort for Semi-Quantitative Reporting of SARS-CoV-2 PCR Test Results in Belgium

P. Maes, B. Bearzatto, E. André, 2022, Viruses.

Shorter serial intervals in SARS-CoV-2 cases with Omicron BA.1 variant compared with Delta variant, the Netherlands, 13 to 26 December 2021

J. Wallinga, D. Eggink, S. van den Hof, 2022, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

Sensitivity and specificity of the Cozart microplate EIA cocaine oral fluid at proposed screening and confirmation cutoffs.

M. Huestis, C. Reid, Insook Kim, 2003, Clinical chemistry.

Plasma and oral fluid pharmacokinetics and pharmacodynamics after oral codeine administration.

M. Huestis, E. Cone, Insook Kim, 2002, Clinical chemistry.